Biologics
Asahi Kasei Expands Sonanos™ Portfolio with Two New Specialty Excipient Grades
Asahi Kasei, a trusted provider in healthcare materials and technology, announced that it will launch two new specialty grades in its Sonanos™ portfo...
October 13, 2025 | News
Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy
Efficacy signals were observed in an interim analysis of a Phase 2 clinical trial for ONO-2808, a S1P5 receptor agonist Phase 2 clinical trial was con...
October 13, 2025 | News
C-Ray Therapeutics Commends Biokin on NMPA Approval for Groundbreaking [177Lu]-BL-ARC001 Radiopharmaceutical
C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the N...
October 13, 2025 | News
Chance Pharmaceuticals and Huadong Medicine Partner for Exclusive Commercialisation of CXG87 in China
Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...
October 10, 2025 | News
Samsung Biologics Launches ExellenS™ Framework to Standardise and Accelerate Global Biomanufacturing
ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed ExellenS TM&nbs...
October 10, 2025 | News
biomodal Launches Global Certified Service Provider Network to Expand Access to duet Multiomics Technology
biomodal, an omics-based life sciences technology and analytics company, announced it has launched a Certified Service Provider (CSP) program with pa...
October 10, 2025 | News
Alithea Genomics Launches MERCURIUS™ Spheroid DRUG-seq to Transform 3D Transcriptomic Drug Screening
Alithea Genomics, a leader in next-generation transcriptomic solutions, announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a...
October 10, 2025 | News
Anasens Partners with MAVAND Solutions to Expand DrugAsens™ Rapid Oral-Fluid Drug Testing Across Europe and Australia
Anasens Inc., a developer of rapid, connected point-of-care detection tools, announced it has signed a distribution agreement with MAVAND Soluti...
October 08, 2025 | News
Celaid Therapeutics Secures ¥1.05 Billion in Series B First Close to Advance Next-Generation Stem Cell Therapies
Celaid Therapeutics Inc. announced the successful completion of the 1st Close of its Series B financing round, raising JPY 1.055 billion (US...
October 08, 2025 | News
CCRM Nordic and Bio-Rad Join Forces to Advance Analytical Power in Cell and Gene Therapy Development
CCRM Nordic, a leading organization dedicated to advancing research, development and commercialization of advanced therapy medicinal prod...
October 08, 2025 | News
MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery
MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...
October 08, 2025 | News
Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays
Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...
October 07, 2025 | News
RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...
October 07, 2025 | News
Lonza Expands GMP Portfolio with TheraPEAK® AmpliCell® Cytokines and 293-GT® Medium for Enhanced Cell and Gene Therapy Manufacturing
AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK&r...
October 07, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
